| GRN-Mutant Neurons | |
|---|---|
| Mutation Type | Frontotemporal Dementia |
| Gene Affected | GRN (Progranulin) |
| Common Mutations | Null mutations (frameshift, nonsense), R493X, C496fs, 4del2 |
| Mechanism | Haploinsufficiency (50% reduced progranulin) |
| Disease | [Frontotemporal Dementia](/diseases/frontotemporal-dementia) |
Grn Mutant Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
GRN-mutant neurons carry loss-of-function mutations in the progranulin gene (GRN), which cause familial frontotemporal dementia (FTD) through haploinsufficiency. GRN mutations account for approximately 10-20% of familial FTD cases and lead to reduced progranulin protein levels (approximately 50% of normal), resulting in TDP-43 pathology. These mutations typically cause behavioral variant FTD or primary progressive aphasia.
Progranulin is a secreted growth factor involved in:
GRN mutations cause FTD through:
GRN-mutant neurons exhibit:
| Feature | GRN-Mutant | Control |
|---|---|---|
| Progranulin | ~50% reduced | Normal |
| TDP-43 | Cytoplasmic | Nuclear |
| Lysosomal function | Impaired | Normal |
| Stress response | Heightened vulnerability | Baseline |
| Inflammation | Elevated | Baseline |
GRN mutations affect:
Grn Mutant Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Grn Mutant Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.